Tuberculosis has stalked humanity for as nearly as long as we've been on earth. In this article, we take a look at how UCSF is leading the fight against the leading infectious disease killer.
Martin Kampmann, PhD, and Anna Victoria Molofsky, MD, PhD, are the 2025 recipients of the Bowes Biomedical Investigator award, which supports scientists who take novel approaches and have the potential to make significant contributions to biomedicine. Recipients receive $1.25 million over five years.
A Q&A w/Alison Cohen, PhD, MPH, who is among the estimated 5% of the population with Long COVID. She talks through the implications of Long COVID, and how she applies her scientific and personal experience to research this debilitating condition.
Three new construction cranes have arrived at UCSF's Parnassus Heights campus, marking a major milestone in the construction of the new UCSF Health Helen Diller Hospital and UCSF Barbara and Gerson Bakar Research and Academic Building. The cranes will be used to lift materials and equipment for the new buildings, which are scheduled to open in 2028 and 2030, respectively.
A new UCSF study shows that the human lungs have just as many blood-producing stem cells as bone marrow. These stem cells are a precious resource for a variety of therapies for conditions like leukemia or lung diseases.
COPA syndrome causes lung hemorrhaging starting in childhood. But one in three people with the disease mutation are spared. UCSF scientists have discovered how a separate gene variant protects those relatives – lighting the way to a possible cure.
How did humans evolve brains capable of complex language, civilization, and more? Scientists at UC San Francisco recently found that parts of our chromosomes have evolved at breakneck speeds to give us an edge in brain development compared to apes.
Is artificial turf increasing your risk of injury? UCSF’s chief of the sports medicine and shoulder service Brian Feeley, MD, talks to us about mounting evidence that it does on the heels of his recent study.
The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.
UCSF Health intends to continue regular operations, including emergency care, and expects to be able to maintain the majority of scheduled appointments and surgeries during upcoming strike action.
